A new study shows that neutralising GDF-15 restores immune response in advanced cancers resistant to PD-1 blockade.
Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback